V
Verrica Pharmaceuticals Inc. (VRCA)
NCM – Real Time Price. Currency in USD
4.38
-0.01 (-0.23%)
At close: Mar 27, 2026, 4:00 PM EDT
4.30
-0.08 (-1.83%)
After-hours: Mar 27, 2026, 5:15 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
4.38
-0.01 (-0.23%)
At close: Mar 27, 2026, 4:00 PM EDT
4.30
-0.08 (-1.83%)
After-hours: Mar 27, 2026, 5:15 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.47 | 6.05 | 10 | |
| Quick ratio | 2.33 | 5.63 | 10 | |
| Debt to Equity | 0.07 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | -5.29 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 9M | 5M | 8M | 36M | 36M |
| Gross Profit | 8M | 4M | 5M | 32M | 32M |
| Operating Income | -21M | -63M | -65M | -12M | -12M |
| Net Income | -24M | -67M | -77M | -18M | -18M |
| EBITDA | -21M | -62M | -64M | -11M | -11M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 31.43 | 54.6 | 10 |
| Next quarter | -53.71 | -2120 | 1.0 |
| Current year | -30.21 | 13.99 | 4.5 |
| Next year | 82.64 | 48.33 | 10 |
| Weighted average score | 6.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -64.49 | -2846.71 | -1799.99 | -148.53 | 1.0 |
| Y/Y | 1380.23 | 50.17 | 76.25 | 72.67 | 10 |
| 3y average | 124.87 | -37.07 | -5.62 | -31.14 | 3.3 |
| 5y average | 269.78 | -12.63 | 10.34 | -9.97 | 4.8 |
| Weighted average score | 4.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $30.1M significantly exceed its total debt $1.6M, ensuring strong financial flexibility
Total current assets $40.6M exceed Total current liabilities $16.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-5.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.7M limits the company's ability to reinvest or pay down debt